Protagonist Therapeutics Inc (PTGX)
Financial leverage ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 744,725 | 603,857 | 614,629 | 629,276 | 357,951 | 330,016 | 320,466 | 239,858 | 247,928 | 282,174 | 310,512 | 348,296 | 347,695 | 373,175 | 404,232 | 298,072 | 324,468 | 217,320 | 224,980 | 134,901 |
| Total stockholders’ equity | US$ in thousands | 675,295 | 531,915 | 541,324 | 560,444 | 336,677 | -643,045 | 294,068 | -570,480 | -536,755 | 243,616 | 267,978 | 301,778 | -409,362 | 329,660 | 357,447 | 259,334 | -283,811 | 169,590 | 167,485 | 62,666 |
| Financial leverage ratio | 1.10 | 1.14 | 1.14 | 1.12 | 1.06 | — | 1.09 | — | — | 1.16 | 1.16 | 1.15 | — | 1.13 | 1.13 | 1.15 | — | 1.28 | 1.34 | 2.15 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $744,725K ÷ $675,295K
= 1.10
The financial leverage ratio of Protagonist Therapeutics Inc reflects the company's use of debt to finance its operations and investments. The ratio has shown variations over the periods analyzed, ranging from 1.06 to 2.15. A decreasing trend in the ratio from 2020 to 2021 indicates a reduction in the company's reliance on debt relative to its equity. However, the ratio has remained relatively stable around 1.10 to 1.16 from 2023 to 2024.
A financial leverage ratio above 1 signifies that the company has more debt than equity in its capital structure. This can indicate potential financial risk, as higher debt levels may lead to increased interest payments and financial obligations. On the other hand, a lower ratio suggests a healthier balance between debt and equity financing.
It is important for stakeholders to closely monitor the financial leverage ratio of Protagonist Therapeutics Inc to assess the company's financial risk and ability to meet its debt obligations. Any significant changes in the ratio over time should be analyzed in conjunction with other financial metrics to gain a comprehensive understanding of the company's financial health and stability.
Peer comparison
Dec 31, 2024